Therefore, these results suggested that EGB exerts potent therapeutic properties in cerebral ischemia by targeting astrocytic LCN2 and suppressing neuro-inflammatory injury via the JAK2/STAT3 pathway. The gene discussed is LCN2; the disease is Cerebral ischemia.